In vitro studies demonstrated that inhibiting CDK9 expression not only hindered the proliferation of Rac1P29S melanoma cells but also upregulated the surface expression of PD-L1 and MHC I proteins on tumor cells [356]. The gene discussed is CDK9; the disease is melanoma.